QBIO - Q BioMed nabs federal supply contract for Strontium89

Q BioMed (QBIO) signed an agreement for Strontium89 to be included on the Federal Supply Schedule ((FSS)); final FSS contract is effective Mar.1 and has a five year term.The agreement provides U.S. veterans and other federal government agencies access to Strontium89 for eligible patients.The FSS contract will extend access to Strontium89 to over nine million VA beneficiaries and others within the federal system.Q BioMed is preparing commercially to serve the U.S. Department of Veterans Affairs and DoD with activities that include a VA sales force, formulary and market access, medical education, and marketing.Efforts will commence in March 2021 and build throughout the year as the FSS agreement is translated to clinical use

For further details see:

Q BioMed nabs federal supply contract for Strontium89